Li N. Komatsu

Array ( [id] => 8543376 [patent_doc_number] => 08318667 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 13/202124 [patent_app_country] => US [patent_app_date] => 2010-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22629 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6534295 [patent_doc_number] => 20100204085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'STRUCTURE-BASED DESIGN OF PEPTIDE INHIBITORS OF AMYLOID FIBRILLATION' [patent_app_type] => utility [patent_app_number] => 12/702175 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13374 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204085.pdf [firstpage_image] =>[orig_patent_app_number] => 12702175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744291 [patent_doc_number] => 20120022000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'USE OF A PEPTIDE IN THE TREATMENT OR PREVENTION OF METASTASIS' [patent_app_type] => utility [patent_app_number] => 13/147296 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10806 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022000.pdf [firstpage_image] =>[orig_patent_app_number] => 13147296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744241 [patent_doc_number] => 20120021975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'ANTIBIOTIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/147095 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24598 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021975.pdf [firstpage_image] =>[orig_patent_app_number] => 13147095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413619 [patent_doc_number] => 08697656 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Compounds, in particular peptides, compositions comprising them and cosmetic and dermo-pharmaceutical uses' [patent_app_type] => utility [patent_app_number] => 13/144614 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36304 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13144614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574039 [patent_doc_number] => 20110269695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'NOVEL ANTI-AGING PEPTIDES AND COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING SAME' [patent_app_type] => utility [patent_app_number] => 13/143754 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5217 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269695.pdf [firstpage_image] =>[orig_patent_app_number] => 13143754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574038 [patent_doc_number] => 20110269694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'NOVEL ANTI-AGING PEPTIDES AND COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING SAME' [patent_app_type] => utility [patent_app_number] => 13/143741 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4740 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269694.pdf [firstpage_image] =>[orig_patent_app_number] => 13143741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733285 [patent_doc_number] => 20120015870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'PEPTIDES AND COMPOSITIONS FOR PREVENTION OF CELL ADHESION AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 13/142358 [patent_app_country] => US [patent_app_date] => 2009-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7002 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015870.pdf [firstpage_image] =>[orig_patent_app_number] => 13142358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8649561 [patent_doc_number] => 20130035291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'OBTAINMENT OF BIOACTIVE PRODUCTS FROM COCOA HAVING INHIBITORY ACTIVITY AGAINST THE PEP ENZYME AND ANTIOXIDANT AND/OR ANTINEURODEGENERATIVE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/518787 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4813 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8417594 [patent_doc_number] => 20120245094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'COMPOUNDS, COMPOSITIONS AND USE' [patent_app_type] => utility [patent_app_number] => 13/141465 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19798 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043361 [patent_doc_number] => 20120071394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'NOVEL POLYPEPTIDES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/142835 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 35683 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071394.pdf [firstpage_image] =>[orig_patent_app_number] => 13142835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490090 [patent_doc_number] => 20110237500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'CECROPIN-MAGAININ HYBRID PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/131829 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3464 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237500.pdf [firstpage_image] =>[orig_patent_app_number] => 13131829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703866 [patent_doc_number] => 08828929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof' [patent_app_type] => utility [patent_app_number] => 13/131560 [patent_app_country] => US [patent_app_date] => 2009-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11864 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13131560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744235 [patent_doc_number] => 20120021973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Peptides for Treatment of Obesity' [patent_app_type] => utility [patent_app_number] => 13/130839 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25034 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021973.pdf [firstpage_image] =>[orig_patent_app_number] => 13130839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696167 [patent_doc_number] => 20110230423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'THERAPY AND MEDICAMENT USING INTEGRIN LIGANDS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/130398 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 67059 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230423.pdf [firstpage_image] =>[orig_patent_app_number] => 13130398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720823 [patent_doc_number] => 20120010158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'TUMOR NECROSIS FACTOR INHIBITING PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/130267 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13295 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010158.pdf [firstpage_image] =>[orig_patent_app_number] => 13130267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663604 [patent_doc_number] => 20110312873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'N-TERMINALLY MODIFIED TETRAPEPTIDE DERIVATIVES HAVING A C-TERMINAL ARGININE MIMETIC' [patent_app_type] => utility [patent_app_number] => 13/126504 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10787 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312873.pdf [firstpage_image] =>[orig_patent_app_number] => 13126504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696174 [patent_doc_number] => 20110230416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'PEPTIDE DERIVATIVES AND USE THEREOF AS CARRIERS FOR MOLECULES IN THE FORM OF CONJUGATES' [patent_app_type] => utility [patent_app_number] => 13/125634 [patent_app_country] => US [patent_app_date] => 2009-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19955 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230416.pdf [firstpage_image] =>[orig_patent_app_number] => 13125634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561721 [patent_doc_number] => 20110275554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/125732 [patent_app_country] => US [patent_app_date] => 2009-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11366 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275554.pdf [firstpage_image] =>[orig_patent_app_number] => 13125732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9009371 [patent_doc_number] => 08524669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'MUC-1 cytoplasmic domain peptides as inhibitors of cancer' [patent_app_type] => utility [patent_app_number] => 12/580865 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 17845 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12580865 [rel_patent_id] =>[rel_patent_doc_number] =>)